US Stock Market Move | Regencell Bioscience Holdings Ltd. (RGC.US) plummeted sharply by over 23%, with its biggest increase of 6681% this year.
On Monday, Renascent Genomic Center (RGC.US) dropped more than 23%, with its stock price hovering dangerously close to $300.
On Monday, Regencell Bioscience Holdings Ltd. (RGC.US) plummeted over 23%, with the stock price almost breaching $300. The stock had been on a continuous rise previously, with the highest increase of 6681% within the year. It is reported that Regencell Bioscience Holdings Ltd. is an early-stage biotech company specializing in traditional Chinese medicine treatments for neurological cognitive disorders and degenerative diseases.
Related Articles
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Guosen: RWA welcomes the era of strict supervision.
Wondershare Technology Group (300624.SZ) has upgraded its Wondershare Filmora desktop version: free video editing, better AI results!
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
